Matthew S. Zore

Matthew Zore practices at Mid Peninsula Endoscopy Center in Burlingame, California.

Matthew Zore's NPI, 1609142785, was assigned on March 22, 2012. Matthew Zore graduated from Indiana University School Of Medicine in 2012. Matthew Zore holds California license A141500.

Matthew Zore's primary practice is Mid Peninsula Endoscopy Center, at 1720 El Camino Real, Suite 100, Burlingame, CA 94010. The practice phone is (650) 373-1970.

Matthew Zore's primary practice is Mid Peninsula Endoscopy Center in Burlingame, California. Matthew Zore is also affiliated with Mills-Peninsula Medical Center. Dmand AI also links Matthew Zore to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Zore practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Matthew Zore's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Matthew Zore is board certified in ophthalmology by the American Board of Ophthalmology. Matthew Zore is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Matthew Zore treats.

CMS data shows 2,914 Medicare services from Matthew Zore across 16 procedure codes in 2024, for 773 Medicare patients. Medicare paid $218,314 for them.

CMS counts 773 Medicare patients who saw Matthew Zore in 2024. The largest group is 75 to 84, with 335 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 7% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Matthew Zore's median patient age at 72, with 57% women.

In 2024, Matthew Zore wrote 1,947 Medicare Part D claims for 447 patients. 54% of them were for generic drugs. CMS names the drug for 1,827 of them, across 19 drugs with 11 or more claims each, at $188,236 in total drug cost. In 2023, CMS named 1,395 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Matthew Zore for performance year 2024, reported as part of a group. Matthew Zore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 48 procedures of cataract surgery by Matthew Zore, more than 62% of the clinicians it reports for that procedure.

CMS Open Payments shows 58 general payments to Matthew Zore from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Alcon Laboratories Inc paid the most, $397.

Matthew Zore graduated from Indiana University School Of Medicine in 2012.

Matthew Zore is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.